Brighthouse Financial
BHF Nasdaq Life & Health Insurance Financials FY2016βFY2025
Brighthouse Financial's revenue rose 43.2% to $6.8 billion in fiscal 2025. Its net margin was 6.4%, down from 8.2% a year earlier. It paid out $102 million in dividends and buybacks. The diluted share count fell 5.9%.
What Brighthouse Financial does
No business description yet.
- Legal name
- Brighthouse Financial, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001685040-26-000011
0001685040
Revenue and margins
Brighthouse Financial had $6.8B of revenue in fiscal 2025, up 43.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Brighthouse Financial returned $102M to shareholders in fiscal 2025. The diluted share count fell 5.9%.
Value Brighthouse Financial yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $3.4B and divides by 57.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 3.6x Β· peers 14.7x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Brighthouse Financial can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $6.3B | $5.2B | $5.0B | $6.9B | $6.6B |
| Debt incl. finance leases | $3.2B | $3.2B | $3.2B | $3.2B | $3.2B |
| Debt / equity | 0.2x | β | β | β | β |
| Interest coverage | 13.3x | 31.9x | β8.6x | 3.8x | 4.1x |
| Total assets | $262.3B | $224.8B | $236.3B | $238.5B | $241.8B |
| Total liabilities | $253.8B | $219.2B | $231.3B | $233.5B | $235.0B |
| Shareholders' equity | $16.1B | $5.5B | $4.9B | $5.0B | $6.8B |
| Net debt (β = net cash) | β$3.2B | β$2.0B | β$1.9B | β$3.8B | β$3.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β0.4% | 0.3% | 0.1% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Brighthouse Financial BHF | $2.6B | 43.2% | β | β | β | 3.6x | β | |
| Globe Life GL | $12.2B | 3.7% | β | 20.9% | 16.0% | 10.3x | β | Compare β |
| CNO Financial Group CNO | $5.1B | 0.9% | 12.3% | β | β | 18.4x | β | Compare β |
| Unum UNM | $14.4B | 1.5% | β | 4.3% | 7.6% | 21.0x | β | Compare β |
| Primerica PRI | $8.6B | 6.6% | β | β | 34.5% | 11.0x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.0B | $6.8B | $9.0B | $6.6B | $8.5B | $5.0B | $6.9B | $4.1B | $4.7B | $6.8B |
| Interest expense | $133M | $135M | $158M | $191M | $184M | $163M | $153M | $153M | $152M | $152M |
| Pretax income | β$4.7B | β$615M | $989M | β$1.1B | β$1.4B | $2.0B | $4.7B | β$1.5B | $422M | $474M |
| Income tax | β$1.8B | β$237M | $119M | β$317M | β$363M | $361M | $848M | β$367M | $29.0M | $36.0M |
| Net income | β$2.9B | β$378M | $865M | β$740M | β$1.1B | $1.6B | $3.9B | β$1.1B | $388M | $433M |
| Diluted EPS | β$24.54 | β$3.16 | $7.21 | β$6.76 | β$11.58 | $18.39 | $51.30 | β$18.39 | $4.64 | $5.71 |
| Diluted shares | 0.12B | 0.12B | 0.12B | 0.11B | 0.10B | 0.08B | 0.07B | 0.07B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $3.7B | $3.4B | $3.1B | $1.8B | $888M | $641M | β$1.2B | β$137M | β$290M | $259M |
| Stock-based compensation | β | β | β | $21.0M | $21.0M | $23.0M | $22.0M | $29.0M | $23.0M | $42.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $105M | $442M | $473M | $499M | $488M | $250M | $250M | $102M |
| Dividends paid | $556M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $556M | $0.0M | $105M | $442M | $473M | $499M | $488M | $250M | $250M | $102M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $6.5B | $2.2B | $4.1B | $4.8B | $7.4B | $6.3B | $5.2B | $5.0B | $6.9B | $6.6B |
| Total debt | $1.9B | $3.6B | $4.0B | $4.4B | $3.4B | $3.2B | $3.2B | $3.2B | $3.2B | $3.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $221.9B | $224.2B | $206.3B | $227.3B | $247.9B | $262.3B | $224.8B | $236.3B | $238.5B | $241.8B |
| Total liabilities | $207.1B | $209.6B | $191.8B | $211.0B | $229.8B | $253.8B | $219.2B | $231.3B | $233.5B | $235.0B |
| Shareholders' equity | $14.9B | $14.5B | $14.4B | $16.2B | $18.0B | $16.1B | $5.5B | $4.9B | $5.0B | $6.8B |
| Margins | ||||||||||
| Net margin | β97.4% | β5.5% | 9.7% | β11.3% | β12.5% | 33.0% | 56.4% | β27.0% | 8.2% | 6.4% |
| Returns | ||||||||||
| Return on equity | β | β2.6% | 6.0% | β4.8% | β6.2% | 9.6% | β | β | β | β |
| Return on assets | β | β0.2% | 0.4% | β0.3% | β0.5% | 0.6% | 1.6% | β0.5% | 0.2% | 0.2% |
| Growth | ||||||||||
| Revenue growth | β66.1% | 126.7% | 31.0% | β26.9% | 29.7% | β41.5% | 38.1% | β40.1% | 14.7% | 43.2% |
| Net income growth | β362.7% | β | β | β185.6% | β | β | 136.1% | β128.7% | β | 11.6% |
| EPS growth | β | β | β | β193.8% | β | β | 179.0% | β135.9% | β | 23.1% |
| Share count change | β | 0.0% | 0.1% | β6.1% | β15.3% | β11.4% | β12.9% | β10.3% | β6.7% | β5.9% |
| Financial health | ||||||||||
| Debt / equity | 0.1x | 0.3x | 0.3x | 0.3x | 0.2x | 0.2x | β | β | β | β |
| Interest coverage | β34.4x | β3.6x | 7.3x | β4.5x | β6.7x | 13.3x | 31.9x | β8.6x | 3.8x | 4.1x |
| Capital allocation | ||||||||||
| Stock comp / revenue | β | β | β | 0.3% | 0.3% | 0.5% | 0.3% | 0.7% | 0.5% | 0.6% |
| Quality scores | ||||||||||
| Accruals ratio | β | β1.7% | β1.0% | β1.2% | β0.8% | 0.4% | 2.1% | β0.4% | 0.3% | 0.1% |
Source: SEC EDGAR XBRL filings (CIK 0001685040). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.